Browse by Medical Category
Accepting New Patients
Obstetrics & Gynecology
Go To Programs
Go To Specialties
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Schorge was born and raised in mid-Michigan. He enrolled in the Honors Program at the University of Michigan, where he became a life-long Wolverines fan and met his future wife. He had a brief immersion in Southern culture during medical school at Vanderbilt University. Dr. Schorge next served an OB/GYN resident at the integrated Brigham & Women's Hospital-Mass General program before completing a gynecologic oncology fellowship at 'the Brigham'. He was on the faculty at the University of Texas Southwestern Medical School-Parkland Memorial Hospital in Dallas for eight years before returning to Boston as Chief of GYN Oncology at Mass General. Dr. Schorge has been married for 20+ years and has three children. He is a member of Red Sox Nation and the entire family proudly wear Tom Brady jerseys [U-Michigan alumnus].
View my most recent publications at PubMed
Schorge JO, Garrett LA, Goodman A. Cytoreductive surgery for advanced ovarian cancer: quo vadis? Oncology 2011;25:928-34.
Rauh-Hain JA, Rodriguez N, Growdon WB, Goodman AK, Boruta DM 2nd, Horowitz NS, Del Carmen MG, Schorge JO. Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer. Ann Surg Oncol 2011 Oct 13.Schorge JO, Bradford LS, del Carmen MG. Primary cytoreductive surgery for advanced ovarian cancer: is it the past, present, or future? Clin Adv Hematol Oncol 2011;9:912-8.
McCann CK, Growdon WB, Munro EG, Del Carmen MG, Boruta DM, Schorge JO, Goodman A. Prognostic significance of splenectomy as part of initial cytoreductive surgery in ovarian cancer. Ann Surg Oncol 2011;18:2912-8. Schorge JO, Modesitt SC, Coleman RL, Cohn DE, Kauff ND, Duska LR, Herzog TJ. SGO White Paper on ovarian cancer: etiology, screening and surveillance. Gynecol Oncol. 2010;119:7-17.
Schorge JO, Wingo, SN, Bhore R, Heffernan TP, Lea JS. Secondary cytoreductive surgery for recurrent platinum-sensitive ovarian cancer. Int J Gynaecol Obstet. 2010;108:123-7.
One of the most serious health sequelae of obesity in women is the development of endometrial intraepithelial neoplasia (EIN) and later endometrial adenocarcinoma, attributed in part to the excess production of estrogen. In fact, the rising obesity rate accounts for a nearly 30% increase in the incidence and mortality rate of endometrial cancer over the past five years, in contrast to a general downtrend for other common malignancies.
The multidisciplinary Minimally Invasive Gynecologic Surgery (MIGS) Center includes specialized surgeons, fellows and a variety of other specialists. Our surgeons take a collaborative approach to patient care to determine the best procedure for each patient. Meet members of the MIGS team and hear one patient's story in this video by the American Congress of Obstetricians and Gynecologists (ACOG).
John Schorge, MD, chief of the Massachusetts General Hospital Gynecologic Oncology Division, discusses the types of treatment options available for patients with reproductive cancers.
Back to Top